NCT02796079

A Clinical Study Using Autologous Bone Marrow Stem Cell for Diabetes Related Vascular Complications

• Status: Unknown
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 240 (estimated)
• Sponsor: Jie Shen · Other Government
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Stem cell therapy has been a new and effective therapy in recent years for diabetic foot.This study intends to establish an optimal clinical research program, and attempts to break the technical bottleneck in the stem cell therapy for treating diabetes related vascular complications.

Detailed description

Diabetic foot is one of the most serious chronic complications of diabetic patients, and still lacking effective treatments. Stem cell therapy has been a new and effective therapy in recent years for diabetic foot. Combined with the previous studies of our research group, this study intends to transform part of the results of this research, establish an optimal clinical research program, and attempts to break the technical bottleneck in the stem cell therapy for treating diabetes related vascular complications.

Conditions

• Peripheral Vascular Disease
• Ischemia
• Diabetic Foot

Interventions

Type	Name	Description
BIOLOGICAL	mesenchymal stem cells	stem cell acquisition, processing and reinfection, to evaluate the efficacy by using autologous bone marrow stem cell
BIOLOGICAL	saline	saline injections

Timeline

• Start date: 2015-01-01
• Primary completion: 2017-12-01
• Completion: 2018-12-01
• First posted: 2016-06-10
• Last updated: 2017-04-06

Locations

1 site across 1 country: China